302 related articles for article (PubMed ID: 19679341)
1. Adjuvant radiation therapy in stage III node-positive uterine cancer.
Schmid S; Hsu IC; Hu JM; Sherman AE; Osann K; Kapp DS; Chan JK
Gynecol Oncol; 2009 Nov; 115(2):239-43. PubMed ID: 19679341
[TBL] [Abstract][Full Text] [Related]
2. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma.
Parthasarathy A; Cheung MK; Osann K; Husain A; Teng NN; Berek JS; Kapp DS; Chan JK
Gynecol Oncol; 2006 Dec; 103(3):1095-9. PubMed ID: 16889821
[TBL] [Abstract][Full Text] [Related]
3. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
Nemani D; Mitra N; Guo M; Lin L
Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer.
Parthasarathy A; Kapp DS; Cheung MK; Shin JY; Osann K; Chan JK
Obstet Gynecol; 2007 Dec; 110(6):1237-43. PubMed ID: 18055715
[TBL] [Abstract][Full Text] [Related]
5. The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma.
Clayton Smith D; Kenneth Macdonald O; Gaffney DK
Radiother Oncol; 2008 Aug; 88(2):227-32. PubMed ID: 18160157
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients.
Chan JK; Cheung MK; Huh WK; Osann K; Husain A; Teng NN; Kapp DS
Cancer; 2006 Oct; 107(8):1823-30. PubMed ID: 16977653
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
8. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
Wright JL; Lin DW; Porter MP
Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
[TBL] [Abstract][Full Text] [Related]
9. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
[TBL] [Abstract][Full Text] [Related]
10. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma.
Hamilton CA; Cheung MK; Osann K; Balzer B; Berman ML; Husain A; Teng NN; Kapp DS; Chan JK
Gynecol Oncol; 2006 Nov; 103(2):679-83. PubMed ID: 16793126
[TBL] [Abstract][Full Text] [Related]
11. The outcomes of 27,063 women with unstaged endometrioid uterine cancer.
Chan JK; Wu H; Cheung MK; Shin JY; Osann K; Kapp DS
Gynecol Oncol; 2007 Aug; 106(2):282-8. PubMed ID: 17662377
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis.
Shridhar R; Dombi GW; Weber J; Hoffe SE; Meredith K; Konski A
Am J Clin Oncol; 2012 Jun; 35(3):216-21. PubMed ID: 21378540
[TBL] [Abstract][Full Text] [Related]
14. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
15. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence.
Fujimoto T; Nanjyo H; Fukuda J; Nakamura A; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2009 Feb; 112(2):342-7. PubMed ID: 19062082
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
Konety BR; Joslyn SA
J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
[TBL] [Abstract][Full Text] [Related]
18. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma.
Hamilton CA; Liou WS; Osann K; Berman ML; Husain A; Teng NN; Kapp DS; Chan JK
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):839-44. PubMed ID: 16199314
[TBL] [Abstract][Full Text] [Related]
19. The role of adjuvant radiation in uterine sarcomas.
Sampath S; Schultheiss TE; Ryu JK; Wong JY
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):728-34. PubMed ID: 19700247
[TBL] [Abstract][Full Text] [Related]
20. The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients.
Chan JK; Kapp DS; Cheung MK; Osann K; Shin JY; Cohn D; Seid PL
Br J Cancer; 2007 Sep; 97(5):605-11. PubMed ID: 17667929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
